​

NEXGEL Stock (NASDAQ:NXGL)

RevenueOwnershipFinancialsChartTranscripts
NEXGEL by TradingView

Previous Close

$0.57

52W Range

$0.48 - $2.89

50D Avg

$0.60

200D Avg

$1.49

Market Cap

$5.39M

Avg Vol (3M)

$213.60K

Beta

0.74

Div Yield

-

NXGL Company Profile

NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

19

IPO Date

Dec 22, 2021

Website

NXGL Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 24Dec 23
Contract Manufacturing$1.98M$1.98M
Other Incomes$243.00K$76.00K

Fiscal year ends in Dec 25 | Currency in USD

NXGL Financial Summary

Dec 25Dec 24Dec 23
Revenue$11.42M$8.69M$4.09M
Operating Income$-3.35M$-3.55M$-3.48M
Net Income$-3.00M$-3.28M$-3.16M
EBITDA$-3.35M$-2.90M$-2.73M
Basic EPS$-0.38$-0.50$-0.56
Diluted EPS$-0.38$-0.50$-0.56

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Apr 21, 26 | 4:30 PM
Q3 25Nov 11, 25 | 4:30 PM
Q2 25Aug 12, 25 | 4:30 PM

Peer Comparison

TickerCompany
HBIOHarvard Bioscience, Inc.
MTVAMetaVia Inc.
FEMYFemasys Inc.
POCIPrecision Optics Corporation, Inc.
GDTCCytoMed Therapeutics Limited
NXLNexalin Technology, Inc.
IINNInspira Technologies Oxy B.H.N. Ltd.
ENLVEnlivex Therapeutics Ltd.